A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection-Reference-Cited by-同舟云学术

A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection

Published:2013-03 Issue:2 Volume:12 Page:282-293
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Yoshida Eric M.,Lilly Leslie B.,Marotta Paul J.,Mason Andrew L.,Bilodeau Marc,Vaillancourt Marc

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference24 articles.

1. Recent findings concerning liver transplantation in the United States;Belle,1996

2. O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology 2008: 1764.

3. Predictors of patient and graft survival following liver transplantation for hepatitis C;Charlton;Hepatology,1998

4. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

5. Clinical characterization of patients developing histologi-cally-proven fibrosing cholestatic hepatitis C post-liver transplantation;Satapathy;Hepatol Res,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling primary biliary cholangitis and primary sclerosing cholangitis as infectious diseases;Translational Autoimmunity;2023

2. Impact of utilization of hepatitis C positive organs in liver transplant: Analysis of united network for organ sharing database;World Journal of Hepatology;2022-05-27

3. Impact of utilization of hepatitis C positive organs in liver transplant: Analysis of united network for organ sharing database;World Journal of Hepatology;2022-05-27

4. Systematic review and meta‐analysis of post‐transplant diabetes mellitus in liver transplant recipients;Clinical Transplantation;2021-06-13

5. Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics;Transplant International;2020-11-28